Published in PLoS One on March 06, 2015
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature (2000) 4.92
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09
Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation (2009) 2.09
Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol (2009) 1.79
2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle. Circ Res (2006) 1.70
HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis. Proc Natl Acad Sci U S A (2013) 1.67
Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J (2009) 1.65
Hydrogen sulfide: a new EDRF. Kidney Int (2009) 1.39
Cardiovascular pharmacology of estradiol metabolites. J Pharmacol Exp Ther (2003) 1.18
2-Methoxyestradiol--biology and mechanism of action. Steroids (2010) 1.17
Potential vascular actions of 2-methoxyestradiol. Trends Endocrinol Metab (2009) 1.07
The endogenous estradiol metabolite 2-methoxyestradiol reduces atherosclerotic lesion formation in female apolipoprotein E-deficient mice. Endocrinology (2007) 0.96
Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension (2010) 0.96
Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J Clin Endocrinol Metab (2008) 0.95
Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures. Life Sci (1999) 0.94
Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders. Br J Pharmacol (2012) 0.88
2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer. Int J Cancer (2007) 0.87
2-Methoxyestradiol attenuates hypertension and coronary vascular remodeling in spontaneously hypertensive rats. Maturitas (2008) 0.87
2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice. J Neurochem (2014) 0.85
17β-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release. Mol Hum Reprod (2012) 0.85
Inhibition of rat aortic smooth muscle contraction by 2-methoxyestradiol. Am J Physiol Heart Circ Physiol (2008) 0.84
Testosterone promotes vascular endothelial cell migration via upregulation of ROCK-2/moesin cascade. Mol Biol Rep (2013) 0.83
Quercetin synergizes with 2-methoxyestradiol inhibiting cell growth and inducing apoptosis in human prostate cancer cells. Oncol Rep (2013) 0.82
Acute effects of 2-methoxyestradiol on endothelial aortic No release in male and ovariectomized female rats. Nitric Oxide (2010) 0.81
Nongenomic inhibition of coronary constriction by 17ß-estradiol, 2-hydroxyestradiol, and 2-methoxyestradiol. Can J Physiol Pharmacol (2010) 0.79
2-Methoxyestradiol, an endogenous estrogen metabolite, sensitizes radioresistant MCF-7/FIR breast cancer cells through multiple mechanisms. Int J Radiat Oncol Biol Phys (2011) 0.78
Pharmacotherapy: Benefits of menopausal hormone therapy--timing is key. Nat Rev Endocrinol (2012) 0.77
Recognition and neutralization of angiotensins I and II using an artificial nanogel receptor fabricated by ligand specificity determinant imprinting. Chem Commun (Camb) (2014) 0.77